"Phenylbutyrates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of 4-phenylbutyric acid, including its salts and esters.
| Descriptor ID |
D010654
|
| MeSH Number(s) |
D02.241.223.651
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phenylbutyrates".
Below are MeSH descriptors whose meaning is more specific than "Phenylbutyrates".
This graph shows the total number of publications written about "Phenylbutyrates" by people in this website by year, and whether "Phenylbutyrates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 2 | 2 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phenylbutyrates" by people in Profiles.
-
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. J Natl Cancer Inst. 2015 Dec; 107(12):djv274.
-
Novel Ammonia-Lowering Agents for Hepatic Encephalopathy. Clin Liver Dis. 2015 Aug; 19(3):539-49.
-
Matrix metalloproteinases and bronchiolitis obliterans: Wrapping the enigma in a riddle. J Thorac Cardiovasc Surg. 2015 Apr; 149(4):1203-4.
-
The effect of glucose concentration and sodium phenylbutyrate treatment on mitochondrial bioenergetics and ER stress in 3T3-L1 adipocytes. Biochim Biophys Acta. 2015 Jan; 1853(1):213-21.
-
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014 Mar; 59(3):1073-83.
-
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab. 2013 Dec; 110(4):446-53.
-
Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas. 2013 Apr; 42(3):467-74.